Form 4 Filing for Grace Therapeutics, Inc.

This filing details a transaction by Prashant Kohli, the Chief Executive Officer and Director of Grace Therapeutics, Inc. On September 9, 2026, Kohli acquired 100,000 shares of common stock at a price of $2.14 per share. Following this transaction, Kohli directly owns 121,357 shares of the company's common stock. The filing was signed on September 10, 2026, by Robert DelAversano as attorney-in-fact for Prashant Kohli. The transaction code "P" indicates a private transaction, and "A" signifies acquisition. This event is classified as an officer/director transaction and is considered to be of medium importance due to the acquisition of a significant number of shares by a key executive.